Arm E

DRUG2 trials

Sponsors

Shandong Suncadia Medicine Co., Ltd., University College London

Conditions

TuberculosisType 2 Diabetes

Phase 1

A HR20031 BE Study on Healthy Subjects

CompletedNCT05682495

Shandong Suncadia Medicine Co., Ltd.Type 2 Diabetes

Start: 2023-01-31End: 2023-04-04Updated: 2023-04-07

Phase 2

Platform Assessing Regimens And Durations In a Global Multisite Consortium for TB [PARADIGM4TB (UNITE4TB – 01)]

Active, not recruitingPACTR202403493915530

University College LondonTuberculosis

Start: 2024-04-15Target: 2500Updated: 2026-08-03